nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—MAP4K1—nipple—uterine fibroid	0.0071	0.0102	CbGeAlD
Nilotinib—EPHB3—nipple—uterine fibroid	0.00644	0.00923	CbGeAlD
Nilotinib—HCK—nipple—uterine fibroid	0.00592	0.00848	CbGeAlD
Nilotinib—CDC42BPB—uterine cervix—uterine fibroid	0.00577	0.00826	CbGeAlD
Nilotinib—CDC42BPB—smooth muscle tissue—uterine fibroid	0.0056	0.00803	CbGeAlD
Nilotinib—EPHB3—myometrium—uterine fibroid	0.00553	0.00792	CbGeAlD
Nilotinib—CDC42BPB—decidua—uterine fibroid	0.00549	0.00787	CbGeAlD
Nilotinib—EPHA4—nipple—uterine fibroid	0.00538	0.00771	CbGeAlD
Nilotinib—CDC42BPB—urethra—uterine fibroid	0.0053	0.00759	CbGeAlD
Nilotinib—MAPK8—uterine cervix—uterine fibroid	0.00521	0.00747	CbGeAlD
Nilotinib—FRK—female reproductive system—uterine fibroid	0.00512	0.00734	CbGeAlD
Nilotinib—HCK—myometrium—uterine fibroid	0.00508	0.00727	CbGeAlD
Nilotinib—MAPK8—smooth muscle tissue—uterine fibroid	0.00507	0.00726	CbGeAlD
Nilotinib—LCK—nipple—uterine fibroid	0.00494	0.00708	CbGeAlD
Nilotinib—CDC42BPB—cardiac atrium—uterine fibroid	0.00483	0.00692	CbGeAlD
Nilotinib—CDC42BPB—uterus—uterine fibroid	0.00481	0.00688	CbGeAlD
Nilotinib—MAPK8—urethra—uterine fibroid	0.00479	0.00686	CbGeAlD
Nilotinib—EPHB4—nipple—uterine fibroid	0.0047	0.00674	CbGeAlD
Nilotinib—EPHA4—myometrium—uterine fibroid	0.00462	0.00661	CbGeAlD
Nilotinib—EPHA2—nipple—uterine fibroid	0.00461	0.00661	CbGeAlD
Nilotinib—CA3—myometrium—uterine fibroid	0.00456	0.00653	CbGeAlD
Nilotinib—TIE1—uterine cervix—uterine fibroid	0.00452	0.00648	CbGeAlD
Nilotinib—MAP4K1—decidua—uterine fibroid	0.00452	0.00647	CbGeAlD
Nilotinib—TIE1—smooth muscle tissue—uterine fibroid	0.00439	0.00629	CbGeAlD
Nilotinib—MAPK11—female reproductive system—uterine fibroid	0.00436	0.00624	CbGeAlD
Nilotinib—MAPK8—uterus—uterine fibroid	0.00435	0.00623	CbGeAlD
Nilotinib—CDC42BPB—female reproductive system—uterine fibroid	0.00432	0.00619	CbGeAlD
Nilotinib—TIE1—decidua—uterine fibroid	0.00431	0.00617	CbGeAlD
Nilotinib—EPHB6—nipple—uterine fibroid	0.0043	0.00616	CbGeAlD
Nilotinib—EPHB3—uterine cervix—uterine fibroid	0.0043	0.00616	CbGeAlD
Nilotinib—FGR—myometrium—uterine fibroid	0.00424	0.00607	CbGeAlD
Nilotinib—TIE1—urethra—uterine fibroid	0.00415	0.00595	CbGeAlD
Nilotinib—MAP4K1—mammalian vulva—uterine fibroid	0.00415	0.00594	CbGeAlD
Nilotinib—EPHB4—myometrium—uterine fibroid	0.00403	0.00578	CbGeAlD
Nilotinib—MAPK11—female gonad—uterine fibroid	0.00396	0.00568	CbGeAlD
Nilotinib—EPHA2—myometrium—uterine fibroid	0.00396	0.00567	CbGeAlD
Nilotinib—EPHB3—urethra—uterine fibroid	0.00395	0.00566	CbGeAlD
Nilotinib—HCK—uterine cervix—uterine fibroid	0.00395	0.00566	CbGeAlD
Nilotinib—CDC42BPB—female gonad—uterine fibroid	0.00393	0.00563	CbGeAlD
Nilotinib—BRAF—endometrium—uterine fibroid	0.00392	0.00562	CbGeAlD
Nilotinib—CDC42BPB—vagina—uterine fibroid	0.00391	0.0056	CbGeAlD
Nilotinib—MAPK8—female reproductive system—uterine fibroid	0.00391	0.0056	CbGeAlD
Nilotinib—EPHA6—female reproductive system—uterine fibroid	0.00391	0.0056	CbGeAlD
Nilotinib—EPHB3—endometrium—uterine fibroid	0.00389	0.00557	CbGeAlD
Nilotinib—TIE1—cardiac atrium—uterine fibroid	0.00379	0.00543	CbGeAlD
Nilotinib—TIE1—uterus—uterine fibroid	0.00377	0.0054	CbGeAlD
Nilotinib—HCK—decidua—uterine fibroid	0.00377	0.00539	CbGeAlD
Nilotinib—EPHB3—mammalian vulva—uterine fibroid	0.00376	0.00539	CbGeAlD
Nilotinib—EPHB6—myometrium—uterine fibroid	0.00369	0.00529	CbGeAlD
Nilotinib—MAP2K5—nipple—uterine fibroid	0.00368	0.00527	CbGeAlD
Nilotinib—HCK—urethra—uterine fibroid	0.00363	0.0052	CbGeAlD
Nilotinib—BRAF—uterus—uterine fibroid	0.00361	0.00517	CbGeAlD
Nilotinib—CSF1R—nipple—uterine fibroid	0.00359	0.00514	CbGeAlD
Nilotinib—EPHB3—uterus—uterine fibroid	0.00358	0.00513	CbGeAlD
Nilotinib—HCK—endometrium—uterine fibroid	0.00357	0.00512	CbGeAlD
Nilotinib—MAPK8—female gonad—uterine fibroid	0.00355	0.00509	CbGeAlD
Nilotinib—CA3—uterine cervix—uterine fibroid	0.00355	0.00508	CbGeAlD
Nilotinib—MAPK8—vagina—uterine fibroid	0.00353	0.00506	CbGeAlD
Nilotinib—HCK—mammalian vulva—uterine fibroid	0.00346	0.00495	CbGeAlD
Nilotinib—TIE1—female reproductive system—uterine fibroid	0.00339	0.00485	CbGeAlD
Nilotinib—MAPK14—uterine cervix—uterine fibroid	0.00331	0.00474	CbGeAlD
Nilotinib—EPHA4—urethra—uterine fibroid	0.0033	0.00473	CbGeAlD
Nilotinib—LCK—uterine cervix—uterine fibroid	0.0033	0.00472	CbGeAlD
Nilotinib—HCK—uterus—uterine fibroid	0.00329	0.00472	CbGeAlD
Nilotinib—KIT—nipple—uterine fibroid	0.00326	0.00467	CbGeAlD
Nilotinib—EPHB3—female reproductive system—uterine fibroid	0.00322	0.00462	CbGeAlD
Nilotinib—MAPK14—smooth muscle tissue—uterine fibroid	0.00322	0.00461	CbGeAlD
Nilotinib—MAP4K1—vagina—uterine fibroid	0.00321	0.0046	CbGeAlD
Nilotinib—PDGFRB—nipple—uterine fibroid	0.00318	0.00456	CbGeAlD
Nilotinib—MAP2K5—myometrium—uterine fibroid	0.00316	0.00452	CbGeAlD
Nilotinib—MAPK14—decidua—uterine fibroid	0.00316	0.00452	CbGeAlD
Nilotinib—FGR—decidua—uterine fibroid	0.00314	0.0045	CbGeAlD
Nilotinib—LCK—decidua—uterine fibroid	0.00314	0.0045	CbGeAlD
Nilotinib—EPHA4—mammalian vulva—uterine fibroid	0.00314	0.0045	CbGeAlD
Nilotinib—EPHB4—uterine cervix—uterine fibroid	0.00314	0.0045	CbGeAlD
Nilotinib—TIE1—female gonad—uterine fibroid	0.00308	0.00442	CbGeAlD
Nilotinib—EPHA2—uterine cervix—uterine fibroid	0.00308	0.00441	CbGeAlD
Nilotinib—CSF1R—myometrium—uterine fibroid	0.00308	0.00441	CbGeAlD
Nilotinib—EPHB4—smooth muscle tissue—uterine fibroid	0.00305	0.00437	CbGeAlD
Nilotinib—FGR—urethra—uterine fibroid	0.00303	0.00434	CbGeAlD
Nilotinib—LCK—urethra—uterine fibroid	0.00303	0.00434	CbGeAlD
Nilotinib—EPHA4—cardiac atrium—uterine fibroid	0.00301	0.00431	CbGeAlD
Nilotinib—EPHA4—uterus—uterine fibroid	0.00299	0.00429	CbGeAlD
Nilotinib—EPHB4—decidua—uterine fibroid	0.00299	0.00428	CbGeAlD
Nilotinib—FGR—endometrium—uterine fibroid	0.00298	0.00427	CbGeAlD
Nilotinib—CA3—cardiac atrium—uterine fibroid	0.00297	0.00426	CbGeAlD
Nilotinib—CA3—uterus—uterine fibroid	0.00296	0.00424	CbGeAlD
Nilotinib—BRAF—female gonad—uterine fibroid	0.00296	0.00423	CbGeAlD
Nilotinib—BRAF—vagina—uterine fibroid	0.00294	0.00421	CbGeAlD
Nilotinib—EPHA2—decidua—uterine fibroid	0.00293	0.0042	CbGeAlD
Nilotinib—EPHB3—female gonad—uterine fibroid	0.00293	0.0042	CbGeAlD
Nilotinib—TEK—smooth muscle tissue—uterine fibroid	0.00292	0.00418	CbGeAlD
Nilotinib—EPHB3—vagina—uterine fibroid	0.00291	0.00417	CbGeAlD
Nilotinib—FGR—mammalian vulva—uterine fibroid	0.00289	0.00413	CbGeAlD
Nilotinib—LCK—mammalian vulva—uterine fibroid	0.00289	0.00413	CbGeAlD
Nilotinib—EPHB4—urethra—uterine fibroid	0.00288	0.00413	CbGeAlD
Nilotinib—EPHB6—uterine cervix—uterine fibroid	0.00287	0.00411	CbGeAlD
Nilotinib—TEK—decidua—uterine fibroid	0.00286	0.0041	CbGeAlD
Nilotinib—EPHB4—endometrium—uterine fibroid	0.00284	0.00407	CbGeAlD
Nilotinib—ABL1—nipple—uterine fibroid	0.00284	0.00406	CbGeAlD
Nilotinib—EPHA2—urethra—uterine fibroid	0.00283	0.00405	CbGeAlD
Nilotinib—KIT—myometrium—uterine fibroid	0.0028	0.00401	CbGeAlD
Nilotinib—EPHA2—endometrium—uterine fibroid	0.00279	0.00399	CbGeAlD
Nilotinib—TEK—urethra—uterine fibroid	0.00276	0.00395	CbGeAlD
Nilotinib—MAPK14—uterus—uterine fibroid	0.00276	0.00395	CbGeAlD
Nilotinib—LCK—uterus—uterine fibroid	0.00275	0.00394	CbGeAlD
Nilotinib—EPHB4—mammalian vulva—uterine fibroid	0.00275	0.00393	CbGeAlD
Nilotinib—EPHB6—decidua—uterine fibroid	0.00274	0.00392	CbGeAlD
Nilotinib—PDGFRB—myometrium—uterine fibroid	0.00273	0.00391	CbGeAlD
Nilotinib—TEK—endometrium—uterine fibroid	0.00272	0.00389	CbGeAlD
Nilotinib—CA14—cardiac atrium—uterine fibroid	0.0027	0.00387	CbGeAlD
Nilotinib—EPHA2—mammalian vulva—uterine fibroid	0.00269	0.00386	CbGeAlD
Nilotinib—HCK—female gonad—uterine fibroid	0.00269	0.00386	CbGeAlD
Nilotinib—EPHA4—female reproductive system—uterine fibroid	0.00269	0.00385	CbGeAlD
Nilotinib—HCK—vagina—uterine fibroid	0.00268	0.00384	CbGeAlD
Nilotinib—ABL2—female gonad—uterine fibroid	0.00268	0.00383	CbGeAlD
Nilotinib—ABL2—vagina—uterine fibroid	0.00266	0.00381	CbGeAlD
Nilotinib—PDGFRA—smooth muscle tissue—uterine fibroid	0.00265	0.00379	CbGeAlD
Nilotinib—EPHB6—urethra—uterine fibroid	0.00264	0.00378	CbGeAlD
Nilotinib—EPHB4—cardiac atrium—uterine fibroid	0.00263	0.00377	CbGeAlD
Nilotinib—EPHB4—uterus—uterine fibroid	0.00262	0.00375	CbGeAlD
Nilotinib—EPHB6—endometrium—uterine fibroid	0.0026	0.00372	CbGeAlD
Nilotinib—PDGFRA—decidua—uterine fibroid	0.00259	0.00371	CbGeAlD
Nilotinib—EPHA2—cardiac atrium—uterine fibroid	0.00258	0.0037	CbGeAlD
Nilotinib—CA9—female reproductive system—uterine fibroid	0.00254	0.00365	CbGeAlD
Nilotinib—TEK—cardiac atrium—uterine fibroid	0.00252	0.00361	CbGeAlD
Nilotinib—EPHB6—mammalian vulva—uterine fibroid	0.00251	0.0036	CbGeAlD
Nilotinib—TEK—uterus—uterine fibroid	0.0025	0.00359	CbGeAlD
Nilotinib—MAPK14—female reproductive system—uterine fibroid	0.00248	0.00355	CbGeAlD
Nilotinib—FGR—female reproductive system—uterine fibroid	0.00247	0.00354	CbGeAlD
Nilotinib—MAP2K5—uterine cervix—uterine fibroid	0.00246	0.00352	CbGeAlD
Nilotinib—EPHA4—female gonad—uterine fibroid	0.00245	0.00351	CbGeAlD
Nilotinib—ABL1—myometrium—uterine fibroid	0.00243	0.00349	CbGeAlD
Nilotinib—EPHA4—vagina—uterine fibroid	0.00243	0.00349	CbGeAlD
Nilotinib—EPHB6—cardiac atrium—uterine fibroid	0.00241	0.00345	CbGeAlD
Nilotinib—CA3—vagina—uterine fibroid	0.0024	0.00344	CbGeAlD
Nilotinib—CSF1R—uterine cervix—uterine fibroid	0.0024	0.00343	CbGeAlD
Nilotinib—EPHB4—female reproductive system—uterine fibroid	0.00235	0.00337	CbGeAlD
Nilotinib—MAP2K5—decidua—uterine fibroid	0.00234	0.00335	CbGeAlD
Nilotinib—CA4—nipple—uterine fibroid	0.00233	0.00334	CbGeAlD
Nilotinib—CSF1R—smooth muscle tissue—uterine fibroid	0.00233	0.00334	CbGeAlD
Nilotinib—EPHA2—female reproductive system—uterine fibroid	0.00231	0.00331	CbGeAlD
Nilotinib—CSF1R—decidua—uterine fibroid	0.00228	0.00327	CbGeAlD
Nilotinib—PDGFRA—uterus—uterine fibroid	0.00227	0.00325	CbGeAlD
Nilotinib—MAPK14—female gonad—uterine fibroid	0.00226	0.00323	CbGeAlD
Nilotinib—MAP2K5—urethra—uterine fibroid	0.00226	0.00323	CbGeAlD
Nilotinib—TEK—female reproductive system—uterine fibroid	0.00225	0.00322	CbGeAlD
Nilotinib—FGR—female gonad—uterine fibroid	0.00225	0.00322	CbGeAlD
Nilotinib—LCK—female gonad—uterine fibroid	0.00225	0.00322	CbGeAlD
Nilotinib—MAPK14—vagina—uterine fibroid	0.00224	0.00321	CbGeAlD
Nilotinib—LCK—vagina—uterine fibroid	0.00223	0.0032	CbGeAlD
Nilotinib—FGR—vagina—uterine fibroid	0.00223	0.0032	CbGeAlD
Nilotinib—MAP2K5—endometrium—uterine fibroid	0.00222	0.00318	CbGeAlD
Nilotinib—CSF1R—urethra—uterine fibroid	0.0022	0.00315	CbGeAlD
Nilotinib—KIT—uterine cervix—uterine fibroid	0.00218	0.00312	CbGeAlD
Nilotinib—CSF1R—endometrium—uterine fibroid	0.00217	0.0031	CbGeAlD
Nilotinib—MAP2K5—mammalian vulva—uterine fibroid	0.00215	0.00308	CbGeAlD
Nilotinib—EPHB4—female gonad—uterine fibroid	0.00214	0.00307	CbGeAlD
Nilotinib—EPHB4—vagina—uterine fibroid	0.00213	0.00305	CbGeAlD
Nilotinib—PDGFRB—uterine cervix—uterine fibroid	0.00213	0.00304	CbGeAlD
Nilotinib—KIT—smooth muscle tissue—uterine fibroid	0.00211	0.00303	CbGeAlD
Nilotinib—EPHA2—female gonad—uterine fibroid	0.0021	0.00301	CbGeAlD
Nilotinib—CSF1R—mammalian vulva—uterine fibroid	0.0021	0.003	CbGeAlD
Nilotinib—EPHA2—vagina—uterine fibroid	0.00209	0.00299	CbGeAlD
Nilotinib—KIT—decidua—uterine fibroid	0.00207	0.00297	CbGeAlD
Nilotinib—PDGFRB—smooth muscle tissue—uterine fibroid	0.00207	0.00296	CbGeAlD
Nilotinib—MAP2K5—cardiac atrium—uterine fibroid	0.00206	0.00295	CbGeAlD
Nilotinib—TEK—female gonad—uterine fibroid	0.00205	0.00293	CbGeAlD
Nilotinib—PDGFRA—female reproductive system—uterine fibroid	0.00204	0.00292	CbGeAlD
Nilotinib—PDGFRB—decidua—uterine fibroid	0.00202	0.0029	CbGeAlD
Nilotinib—CSF1R—cardiac atrium—uterine fibroid	0.00201	0.00288	CbGeAlD
Nilotinib—KIT—urethra—uterine fibroid	0.002	0.00286	CbGeAlD
Nilotinib—CSF1R—uterus—uterine fibroid	0.002	0.00286	CbGeAlD
Nilotinib—KIT—endometrium—uterine fibroid	0.00197	0.00282	CbGeAlD
Nilotinib—EPHB6—female gonad—uterine fibroid	0.00196	0.0028	CbGeAlD
Nilotinib—PDGFRB—urethra—uterine fibroid	0.00195	0.0028	CbGeAlD
Nilotinib—EPHB6—vagina—uterine fibroid	0.00195	0.00279	CbGeAlD
Nilotinib—CA2—nipple—uterine fibroid	0.00193	0.00277	CbGeAlD
Nilotinib—PDGFRB—endometrium—uterine fibroid	0.00192	0.00275	CbGeAlD
Nilotinib—KIT—mammalian vulva—uterine fibroid	0.0019	0.00273	CbGeAlD
Nilotinib—ABL1—uterine cervix—uterine fibroid	0.00189	0.00271	CbGeAlD
Nilotinib—CA12—female reproductive system—uterine fibroid	0.00188	0.0027	CbGeAlD
Nilotinib—PDGFRB—mammalian vulva—uterine fibroid	0.00186	0.00266	CbGeAlD
Nilotinib—PDGFRA—female gonad—uterine fibroid	0.00186	0.00266	CbGeAlD
Nilotinib—PDGFRA—vagina—uterine fibroid	0.00184	0.00264	CbGeAlD
Nilotinib—ABL1—smooth muscle tissue—uterine fibroid	0.00184	0.00264	CbGeAlD
Nilotinib—MAP2K5—female reproductive system—uterine fibroid	0.00184	0.00264	CbGeAlD
Nilotinib—KIT—uterus—uterine fibroid	0.00181	0.0026	CbGeAlD
Nilotinib—ABL1—decidua—uterine fibroid	0.0018	0.00259	CbGeAlD
Nilotinib—CSF1R—female reproductive system—uterine fibroid	0.0018	0.00257	CbGeAlD
Nilotinib—PDGFRB—cardiac atrium—uterine fibroid	0.00178	0.00255	CbGeAlD
Nilotinib—PDGFRB—uterus—uterine fibroid	0.00177	0.00254	CbGeAlD
Nilotinib—ABL1—urethra—uterine fibroid	0.00174	0.00249	CbGeAlD
Nilotinib—ABL1—endometrium—uterine fibroid	0.00171	0.00245	CbGeAlD
Nilotinib—MAP2K5—female gonad—uterine fibroid	0.00167	0.0024	CbGeAlD
Nilotinib—MAP2K5—vagina—uterine fibroid	0.00166	0.00238	CbGeAlD
Nilotinib—ABL1—mammalian vulva—uterine fibroid	0.00166	0.00237	CbGeAlD
Nilotinib—CSF1R—female gonad—uterine fibroid	0.00163	0.00234	CbGeAlD
Nilotinib—KIT—female reproductive system—uterine fibroid	0.00163	0.00234	CbGeAlD
Nilotinib—CSF1R—vagina—uterine fibroid	0.00162	0.00233	CbGeAlD
Nilotinib—PDGFRB—female reproductive system—uterine fibroid	0.00159	0.00228	CbGeAlD
Nilotinib—ABL1—cardiac atrium—uterine fibroid	0.00159	0.00227	CbGeAlD
Nilotinib—ABL1—uterus—uterine fibroid	0.00158	0.00226	CbGeAlD
Nilotinib—ABCG2—myometrium—uterine fibroid	0.00154	0.0022	CbGeAlD
Nilotinib—CA1—female reproductive system—uterine fibroid	0.00149	0.00214	CbGeAlD
Nilotinib—KIT—female gonad—uterine fibroid	0.00148	0.00213	CbGeAlD
Nilotinib—KIT—vagina—uterine fibroid	0.00147	0.00211	CbGeAlD
Nilotinib—PDGFRB—female gonad—uterine fibroid	0.00145	0.00208	CbGeAlD
Nilotinib—PDGFRB—vagina—uterine fibroid	0.00144	0.00206	CbGeAlD
Nilotinib—CA4—urethra—uterine fibroid	0.00143	0.00205	CbGeAlD
Nilotinib—LCK—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.00142	0.0047	CbGpPWpGaD
Nilotinib—ABL1—female reproductive system—uterine fibroid	0.00142	0.00203	CbGeAlD
Nilotinib—PDGFRB—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.0014	0.00463	CbGpPWpGaD
Nilotinib—PDGFRA—Downstream signal transduction—TNRC6B—uterine fibroid	0.00139	0.00462	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by FGFR—TNRC6B—uterine fibroid	0.00139	0.0046	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00138	0.00458	CbGpPWpGaD
Nilotinib—MAPK8—Cellular responses to stress—TNRC6B—uterine fibroid	0.00138	0.00457	CbGpPWpGaD
Nilotinib—MAPK14—ATF-2 transcription factor network—ESR1—uterine fibroid	0.00138	0.00456	CbGpPWpGaD
Nilotinib—PDGFRA—DAP12 signaling—TNRC6B—uterine fibroid	0.00137	0.00455	CbGpPWpGaD
Nilotinib—LYN—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00137	0.00453	CbGpPWpGaD
Nilotinib—KIT—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00137	0.00453	CbGpPWpGaD
Nilotinib—KIT—DAP12 interactions—TNRC6B—uterine fibroid	0.00137	0.00453	CbGpPWpGaD
Nilotinib—KIT—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00137	0.00453	CbGpPWpGaD
Nilotinib—CA12—Metabolism—HPSE2—uterine fibroid	0.00136	0.0045	CbGpPWpGaD
Nilotinib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00135	0.00449	CbGpPWpGaD
Nilotinib—KIT—Signaling by EGFR—TNRC6B—uterine fibroid	0.00135	0.00448	CbGpPWpGaD
Nilotinib—KIT—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00134	0.00444	CbGpPWpGaD
Nilotinib—MAPK11—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00134	0.00444	CbGpPWpGaD
Nilotinib—PDGFRB—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00134	0.00443	CbGpPWpGaD
Nilotinib—KIT—Signaling by PDGF—TNRC6B—uterine fibroid	0.00134	0.00443	CbGpPWpGaD
Nilotinib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00134	0.00442	CbGpPWpGaD
Nilotinib—BRAF—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00133	0.0044	CbGpPWpGaD
Nilotinib—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00132	0.00437	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00132	0.00436	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—MED12—uterine fibroid	0.00131	0.00435	CbGpPWpGaD
Nilotinib—CA4—cardiac atrium—uterine fibroid	0.0013	0.00187	CbGeAlD
Nilotinib—PDGFRB—Signaling by ERBB4—PGR—uterine fibroid	0.0013	0.00431	CbGpPWpGaD
Nilotinib—CA9—Cellular responses to stress—TNRC6B—uterine fibroid	0.0013	0.00431	CbGpPWpGaD
Nilotinib—MAPK8—Signaling by NGF—TNRC6B—uterine fibroid	0.0013	0.00429	CbGpPWpGaD
Nilotinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00129	0.00428	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00129	0.00428	CbGpPWpGaD
Nilotinib—PDGFRA—DAP12 interactions—TNRC6B—uterine fibroid	0.00129	0.00428	CbGpPWpGaD
Nilotinib—ABL1—female gonad—uterine fibroid	0.00129	0.00185	CbGeAlD
Nilotinib—ABL1—Regulation of Telomerase—ESR1—uterine fibroid	0.00129	0.00427	CbGpPWpGaD
Nilotinib—ABL1—vagina—uterine fibroid	0.00128	0.00184	CbGeAlD
Nilotinib—PDGFRA—Signaling by EGFR—TNRC6B—uterine fibroid	0.00128	0.00425	CbGpPWpGaD
Nilotinib—CYP2B6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00128	0.00424	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00127	0.00421	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by PDGF—TNRC6B—uterine fibroid	0.00126	0.00419	CbGpPWpGaD
Nilotinib—KIT—B Cell Activation—TNRC6B—uterine fibroid	0.00126	0.00419	CbGpPWpGaD
Nilotinib—PDGFRB—Downstream signal transduction—TNRC6B—uterine fibroid	0.00126	0.00416	CbGpPWpGaD
Nilotinib—CA2—smooth muscle tissue—uterine fibroid	0.00125	0.0018	CbGeAlD
Nilotinib—PDGFRB—Signaling by FGFR—TNRC6B—uterine fibroid	0.00125	0.00414	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00124	0.00412	CbGpPWpGaD
Nilotinib—PDGFRB—DAP12 signaling—TNRC6B—uterine fibroid	0.00124	0.0041	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling by NGF—TNRC6B—uterine fibroid	0.00123	0.00408	CbGpPWpGaD
Nilotinib—CA2—decidua—uterine fibroid	0.00123	0.00176	CbGeAlD
Nilotinib—HCK—Disease—HPSE2—uterine fibroid	0.00122	0.00405	CbGpPWpGaD
Nilotinib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00122	0.00404	CbGpPWpGaD
Nilotinib—KIT—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00121	0.00401	CbGpPWpGaD
Nilotinib—PDGFRA—B Cell Activation—TNRC6B—uterine fibroid	0.0012	0.00396	CbGpPWpGaD
Nilotinib—ABCG2—uterine cervix—uterine fibroid	0.00119	0.00171	CbGeAlD
Nilotinib—CA4—female reproductive system—uterine fibroid	0.00117	0.00167	CbGeAlD
Nilotinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00116	0.00386	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00116	0.00386	CbGpPWpGaD
Nilotinib—PDGFRB—DAP12 interactions—TNRC6B—uterine fibroid	0.00116	0.00386	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by EGFR—TNRC6B—uterine fibroid	0.00115	0.00382	CbGpPWpGaD
Nilotinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00115	0.00379	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00114	0.00379	CbGpPWpGaD
Nilotinib—LYN—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00114	0.00378	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by PDGF—TNRC6B—uterine fibroid	0.00114	0.00377	CbGpPWpGaD
Nilotinib—ABCG2—decidua—uterine fibroid	0.00114	0.00163	CbGeAlD
Nilotinib—MAPK14—Leptin signaling pathway—ESR1—uterine fibroid	0.00114	0.00376	CbGpPWpGaD
Nilotinib—CA2—mammalian vulva—uterine fibroid	0.00113	0.00162	CbGeAlD
Nilotinib—LCK—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00112	0.00371	CbGpPWpGaD
Nilotinib—CYP2C8—endometrium—uterine fibroid	0.00111	0.00159	CbGeAlD
Nilotinib—MAPK11—Cellular responses to stress—TNRC6B—uterine fibroid	0.0011	0.00364	CbGpPWpGaD
Nilotinib—ABCG2—urethra—uterine fibroid	0.0011	0.00157	CbGeAlD
Nilotinib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.0011	0.00363	CbGpPWpGaD
Nilotinib—UGT1A1—Biological oxidations—CYP17A1—uterine fibroid	0.00109	0.00362	CbGpPWpGaD
Nilotinib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00109	0.0036	CbGpPWpGaD
Nilotinib—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00108	0.00359	CbGpPWpGaD
Nilotinib—CA4—Metabolism—HPSE2—uterine fibroid	0.00108	0.00359	CbGpPWpGaD
Nilotinib—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00108	0.00358	CbGpPWpGaD
Nilotinib—CA2—cardiac atrium—uterine fibroid	0.00108	0.00155	CbGeAlD
Nilotinib—ABCG2—endometrium—uterine fibroid	0.00108	0.00155	CbGeAlD
Nilotinib—PDGFRB—B Cell Activation—TNRC6B—uterine fibroid	0.00108	0.00357	CbGpPWpGaD
Nilotinib—UGT1A1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00108	0.00357	CbGpPWpGaD
Nilotinib—LCK—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00107	0.00355	CbGpPWpGaD
Nilotinib—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00107	0.00355	CbGpPWpGaD
Nilotinib—CA3—Metabolism—MED12—uterine fibroid	0.00107	0.00355	CbGpPWpGaD
Nilotinib—CA4—female gonad—uterine fibroid	0.00106	0.00152	CbGeAlD
Nilotinib—LCK—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00106	0.0035	CbGpPWpGaD
Nilotinib—LYN—B Cell Activation—TNRC6B—uterine fibroid	0.00106	0.0035	CbGpPWpGaD
Nilotinib—LCK—Signaling by ERBB4—PGR—uterine fibroid	0.00105	0.00346	CbGpPWpGaD
Nilotinib—ABCG2—mammalian vulva—uterine fibroid	0.00105	0.0015	CbGeAlD
Nilotinib—MAPK14—Cellular Senescence—TNRC6B—uterine fibroid	0.00104	0.00344	CbGpPWpGaD
Nilotinib—CA2—Metabolism—HPSE2—uterine fibroid	0.00104	0.00344	CbGpPWpGaD
Nilotinib—MAPK11—Signaling by NGF—TNRC6B—uterine fibroid	0.00103	0.00342	CbGpPWpGaD
Nilotinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00103	0.00342	CbGpPWpGaD
Nilotinib—BRAF—Signaling by NGF—TNRC6B—uterine fibroid	0.00102	0.00339	CbGpPWpGaD
Nilotinib—LCK—Downstream signal transduction—TNRC6B—uterine fibroid	0.00101	0.00334	CbGpPWpGaD
Nilotinib—LCK—Signaling by FGFR—TNRC6B—uterine fibroid	0.001	0.00332	CbGpPWpGaD
Nilotinib—LCK—Signaling by ERBB2—TNRC6B—uterine fibroid	0.000999	0.00331	CbGpPWpGaD
Nilotinib—ABCG2—uterus—uterine fibroid	0.000996	0.00143	CbGeAlD
Nilotinib—CA1—Metabolism—HPSE2—uterine fibroid	0.000995	0.0033	CbGpPWpGaD
Nilotinib—LCK—DAP12 signaling—TNRC6B—uterine fibroid	0.000994	0.00329	CbGpPWpGaD
Nilotinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.000979	0.00324	CbGpPWpGaD
Nilotinib—CA2—female reproductive system—uterine fibroid	0.000966	0.00138	CbGeAlD
Nilotinib—MAPK14—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000958	0.00317	CbGpPWpGaD
Nilotinib—MAPK8—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000946	0.00313	CbGpPWpGaD
Nilotinib—LCK—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.000935	0.0031	CbGpPWpGaD
Nilotinib—LCK—DAP12 interactions—TNRC6B—uterine fibroid	0.000935	0.0031	CbGpPWpGaD
Nilotinib—LCK—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.000935	0.0031	CbGpPWpGaD
Nilotinib—KIT—Signaling by NGF—TNRC6B—uterine fibroid	0.000931	0.00308	CbGpPWpGaD
Nilotinib—LCK—Signaling by EGFR—TNRC6B—uterine fibroid	0.000927	0.00307	CbGpPWpGaD
Nilotinib—CYP2C8—female reproductive system—uterine fibroid	0.00092	0.00132	CbGeAlD
Nilotinib—LCK—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000918	0.00304	CbGpPWpGaD
Nilotinib—LCK—Signaling by PDGF—TNRC6B—uterine fibroid	0.000914	0.00303	CbGpPWpGaD
Nilotinib—BRAF—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000901	0.00298	CbGpPWpGaD
Nilotinib—CA3—Metabolism—CYP17A1—uterine fibroid	0.000896	0.00297	CbGpPWpGaD
Nilotinib—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000889	0.00294	CbGpPWpGaD
Nilotinib—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000881	0.00292	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by NGF—TNRC6B—uterine fibroid	0.000881	0.00292	CbGpPWpGaD
Nilotinib—CA2—female gonad—uterine fibroid	0.000879	0.00126	CbGeAlD
Nilotinib—BRAF—Disease—HPSE2—uterine fibroid	0.000875	0.0029	CbGpPWpGaD
Nilotinib—CA9—Metabolism—HPSE2—uterine fibroid	0.000875	0.0029	CbGpPWpGaD
Nilotinib—CA2—vagina—uterine fibroid	0.000874	0.00125	CbGeAlD
Nilotinib—LCK—B Cell Activation—TNRC6B—uterine fibroid	0.000865	0.00287	CbGpPWpGaD
Nilotinib—CYP2C8—vagina—uterine fibroid	0.000832	0.00119	CbGeAlD
Nilotinib—LCK—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000828	0.00274	CbGpPWpGaD
Nilotinib—CYP2B6—female reproductive system—uterine fibroid	0.000826	0.00118	CbGeAlD
Nilotinib—CYP2C9—female reproductive system—uterine fibroid	0.000818	0.00117	CbGeAlD
Nilotinib—KIT—Signaling by ERBB4—ESR1—uterine fibroid	0.000816	0.0027	CbGpPWpGaD
Nilotinib—HCK—Innate Immune System—TNRC6B—uterine fibroid	0.000815	0.0027	CbGpPWpGaD
Nilotinib—ABCG2—female gonad—uterine fibroid	0.000814	0.00117	CbGeAlD
Nilotinib—ABCG2—vagina—uterine fibroid	0.000809	0.00116	CbGeAlD
Nilotinib—KIT—Disease—HPSE2—uterine fibroid	0.000796	0.00264	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—MED12—uterine fibroid	0.000796	0.00264	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by NGF—TNRC6B—uterine fibroid	0.000794	0.00263	CbGpPWpGaD
Nilotinib—MAPK14—Cellular responses to stress—TNRC6B—uterine fibroid	0.000785	0.0026	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by ERBB4—ESR1—uterine fibroid	0.000772	0.00256	CbGpPWpGaD
Nilotinib—ABCB1—myometrium—uterine fibroid	0.000757	0.00108	CbGeAlD
Nilotinib—PDGFRA—Disease—HPSE2—uterine fibroid	0.000754	0.0025	CbGpPWpGaD
Nilotinib—CYP2B6—vagina—uterine fibroid	0.000747	0.00107	CbGeAlD
Nilotinib—MAPK8—Innate Immune System—TNRC6B—uterine fibroid	0.000739	0.00245	CbGpPWpGaD
Nilotinib—MAPK14—Signaling by NGF—TNRC6B—uterine fibroid	0.000737	0.00244	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—TNRC6B—uterine fibroid	0.000736	0.00244	CbGpPWpGaD
Nilotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000717	0.00237	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—TNRC6B—uterine fibroid	0.000709	0.00235	CbGpPWpGaD
Nilotinib—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000707	0.00234	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by ERBB4—ESR1—uterine fibroid	0.000696	0.0023	CbGpPWpGaD
Nilotinib—CA14—Metabolism—MED12—uterine fibroid	0.00069	0.00228	CbGpPWpGaD
Nilotinib—ABL1—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000681	0.00226	CbGpPWpGaD
Nilotinib—CYP2B6—Biological oxidations—CYP17A1—uterine fibroid	0.000679	0.00225	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—HPSE2—uterine fibroid	0.000679	0.00225	CbGpPWpGaD
Nilotinib—CA6—Metabolism—MED12—uterine fibroid	0.000672	0.00223	CbGpPWpGaD
Nilotinib—CYP2B6—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00067	0.00222	CbGpPWpGaD
Nilotinib—PDGFRA—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000643	0.00213	CbGpPWpGaD
Nilotinib—LCK—Signaling by NGF—TNRC6B—uterine fibroid	0.000637	0.00211	CbGpPWpGaD
Nilotinib—CA7—Metabolism—MED12—uterine fibroid	0.000628	0.00208	CbGpPWpGaD
Nilotinib—CYP3A4—female reproductive system—uterine fibroid	0.000623	0.000893	CbGeAlD
Nilotinib—CYP2D6—female reproductive system—uterine fibroid	0.000614	0.000879	CbGeAlD
Nilotinib—LYN—Developmental Biology—MED12—uterine fibroid	0.000599	0.00199	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—MED12—uterine fibroid	0.000597	0.00198	CbGpPWpGaD
Nilotinib—ABCB1—uterine cervix—uterine fibroid	0.000589	0.000844	CbGeAlD
Nilotinib—MAPK11—Innate Immune System—TNRC6B—uterine fibroid	0.000589	0.00195	CbGpPWpGaD
Nilotinib—CA12—Metabolism—MED12—uterine fibroid	0.000581	0.00193	CbGpPWpGaD
Nilotinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000581	0.00192	CbGpPWpGaD
Nilotinib—CA14—Metabolism—CYP17A1—uterine fibroid	0.000577	0.00191	CbGpPWpGaD
Nilotinib—CYP2C8—Biological oxidations—CYP17A1—uterine fibroid	0.000575	0.0019	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—MED12—uterine fibroid	0.000568	0.00188	CbGpPWpGaD
Nilotinib—CYP2C8—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000567	0.00188	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000565	0.00187	CbGpPWpGaD
Nilotinib—CA6—Metabolism—CYP17A1—uterine fibroid	0.000563	0.00186	CbGpPWpGaD
Nilotinib—ABCB1—decidua—uterine fibroid	0.000561	0.000804	CbGeAlD
Nilotinib—CYP2D6—female gonad—uterine fibroid	0.000558	0.0008	CbGeAlD
Nilotinib—LCK—Signaling by ERBB4—ESR1—uterine fibroid	0.000558	0.00185	CbGpPWpGaD
Nilotinib—LCK—Disease—HPSE2—uterine fibroid	0.000545	0.00181	CbGpPWpGaD
Nilotinib—ABCB1—urethra—uterine fibroid	0.000541	0.000775	CbGeAlD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000538	0.00178	CbGpPWpGaD
Nilotinib—ABCB1—endometrium—uterine fibroid	0.000533	0.000763	CbGeAlD
Nilotinib—KIT—Innate Immune System—TNRC6B—uterine fibroid	0.000531	0.00176	CbGpPWpGaD
Nilotinib—CA7—Metabolism—CYP17A1—uterine fibroid	0.000525	0.00174	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—HPSE2—uterine fibroid	0.000521	0.00173	CbGpPWpGaD
Nilotinib—ABCB1—mammalian vulva—uterine fibroid	0.000515	0.000738	CbGeAlD
Nilotinib—KIT—Adaptive Immune System—TNRC6B—uterine fibroid	0.00051	0.00169	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—TNRC6B—uterine fibroid	0.000502	0.00166	CbGpPWpGaD
Nilotinib—ABCB1—uterus—uterine fibroid	0.000491	0.000703	CbGeAlD
Nilotinib—CA12—Metabolism—CYP17A1—uterine fibroid	0.000487	0.00161	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—TNRC6B—uterine fibroid	0.000482	0.0016	CbGpPWpGaD
Nilotinib—HCK—Immune System—TNRC6B—uterine fibroid	0.000475	0.00157	CbGpPWpGaD
Nilotinib—CYP2D6—Biological oxidations—CYP17A1—uterine fibroid	0.000472	0.00156	CbGpPWpGaD
Nilotinib—CYP2C9—Biological oxidations—CYP17A1—uterine fibroid	0.000468	0.00155	CbGpPWpGaD
Nilotinib—CYP2D6—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000466	0.00154	CbGpPWpGaD
Nilotinib—CA4—Metabolism—MED12—uterine fibroid	0.000464	0.00154	CbGpPWpGaD
Nilotinib—CYP2C9—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000462	0.00153	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—TNRC6B—uterine fibroid	0.000453	0.0015	CbGpPWpGaD
Nilotinib—CA2—Metabolism—MED12—uterine fibroid	0.000444	0.00147	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—TNRC6B—uterine fibroid	0.000443	0.00147	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—HPSE2—uterine fibroid	0.000442	0.00146	CbGpPWpGaD
Nilotinib—ABCB1—female reproductive system—uterine fibroid	0.000441	0.000632	CbGeAlD
Nilotinib—ABL1—Innate Immune System—TNRC6B—uterine fibroid	0.000441	0.00146	CbGpPWpGaD
Nilotinib—HCK—Disease—TNRC6B—uterine fibroid	0.000438	0.00145	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—TNRC6B—uterine fibroid	0.000435	0.00144	CbGpPWpGaD
Nilotinib—BLK—Immune System—TNRC6B—uterine fibroid	0.00043	0.00143	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—TNRC6B—uterine fibroid	0.00043	0.00143	CbGpPWpGaD
Nilotinib—FGR—Immune System—TNRC6B—uterine fibroid	0.000429	0.00142	CbGpPWpGaD
Nilotinib—CA1—Metabolism—MED12—uterine fibroid	0.000426	0.00141	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—TNRC6B—uterine fibroid	0.000426	0.00141	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—TNRC6B—uterine fibroid	0.00042	0.00139	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—MED12—uterine fibroid	0.000407	0.00135	CbGpPWpGaD
Nilotinib—ABCB1—female gonad—uterine fibroid	0.000402	0.000575	CbGeAlD
Nilotinib—ABCB1—vagina—uterine fibroid	0.000399	0.000572	CbGeAlD
Nilotinib—CA4—Metabolism—CYP17A1—uterine fibroid	0.000388	0.00129	CbGpPWpGaD
Nilotinib—CA9—Metabolism—MED12—uterine fibroid	0.000375	0.00124	CbGpPWpGaD
Nilotinib—CA2—Metabolism—CYP17A1—uterine fibroid	0.000372	0.00123	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—TNRC6B—uterine fibroid	0.000363	0.0012	CbGpPWpGaD
Nilotinib—CA1—Metabolism—CYP17A1—uterine fibroid	0.000357	0.00118	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—TNRC6B—uterine fibroid	0.000349	0.00116	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—TNRC6B—uterine fibroid	0.000343	0.00114	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—TNRC6B—uterine fibroid	0.000341	0.00113	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—PGR—uterine fibroid	0.000337	0.00112	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—HPSE2—uterine fibroid	0.000324	0.00107	CbGpPWpGaD
Nilotinib—BRAF—Disease—TNRC6B—uterine fibroid	0.000314	0.00104	CbGpPWpGaD
Nilotinib—CA9—Metabolism—CYP17A1—uterine fibroid	0.000314	0.00104	CbGpPWpGaD
Nilotinib—KIT—Immune System—TNRC6B—uterine fibroid	0.000309	0.00102	CbGpPWpGaD
Nilotinib—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	0.000309	0.00102	CbGpPWpGaD
Nilotinib—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000304	0.00101	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—TNRC6B—uterine fibroid	0.000293	0.000969	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—MED12—uterine fibroid	0.000291	0.000963	CbGpPWpGaD
Nilotinib—KIT—Disease—TNRC6B—uterine fibroid	0.000285	0.000945	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TNRC6B—uterine fibroid	0.000278	0.000922	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—PGR—uterine fibroid	0.000275	0.000912	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—HPSE2—uterine fibroid	0.000274	0.000909	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TNRC6B—uterine fibroid	0.00027	0.000895	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TNRC6B—uterine fibroid	0.000265	0.000876	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000264	0.000874	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—TNRC6B—uterine fibroid	0.000264	0.000873	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—PGR—uterine fibroid	0.000262	0.000867	CbGpPWpGaD
Nilotinib—LYN—Immune System—TNRC6B—uterine fibroid	0.000258	0.000855	CbGpPWpGaD
Nilotinib—ABL1—Immune System—TNRC6B—uterine fibroid	0.000257	0.000851	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—TNRC6B—uterine fibroid	0.000245	0.000811	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000244	0.000807	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TNRC6B—uterine fibroid	0.000243	0.000806	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—TNRC6B—uterine fibroid	0.000243	0.000806	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—PGR—uterine fibroid	0.000241	0.000798	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—HPSE2—uterine fibroid	0.000239	0.000792	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—HPSE2—uterine fibroid	0.000225	0.000746	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—HPSE2—uterine fibroid	0.000223	0.00074	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—MED12—uterine fibroid	0.000223	0.000739	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TNRC6B—uterine fibroid	0.000222	0.000734	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000221	0.000732	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TNRC6B—uterine fibroid	0.00022	0.000727	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—PGR—uterine fibroid	0.000219	0.000727	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—PGR—uterine fibroid	0.000217	0.00072	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000215	0.000711	CbGpPWpGaD
Nilotinib—LCK—Immune System—TNRC6B—uterine fibroid	0.000212	0.000701	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TNRC6B—uterine fibroid	0.0002	0.000662	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—PGR—uterine fibroid	0.000198	0.000655	CbGpPWpGaD
Nilotinib—LCK—Disease—TNRC6B—uterine fibroid	0.000195	0.000647	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—MED12—uterine fibroid	0.000189	0.000627	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TNRC6B—uterine fibroid	0.000189	0.000627	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—PGR—uterine fibroid	0.000187	0.00062	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CYP17A1—uterine fibroid	0.000187	0.000619	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—ESR1—uterine fibroid	0.00018	0.000597	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.00018	0.000595	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TNRC6B—uterine fibroid	0.00017	0.000565	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PGR—uterine fibroid	0.000169	0.000559	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TNRC6B—uterine fibroid	0.000167	0.000553	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PGR—uterine fibroid	0.000165	0.000547	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CYP17A1—uterine fibroid	0.000158	0.000525	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TNRC6B—uterine fibroid	0.000158	0.000524	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PGR—uterine fibroid	0.000157	0.000519	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HPSE2—uterine fibroid	0.000147	0.000488	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—ESR1—uterine fibroid	0.000147	0.000487	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—ESR1—uterine fibroid	0.00014	0.000463	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MED12—uterine fibroid	0.000139	0.00046	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TNRC6B—uterine fibroid	0.000137	0.000453	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PGR—uterine fibroid	0.000135	0.000449	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—ESR1—uterine fibroid	0.000129	0.000426	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MED12—uterine fibroid	0.000117	0.000389	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—ESR1—uterine fibroid	0.000117	0.000388	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CYP17A1—uterine fibroid	0.000116	0.000385	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—ESR1—uterine fibroid	0.000116	0.000384	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—ESR1—uterine fibroid	0.000106	0.00035	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MED12—uterine fibroid	0.000102	0.000339	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—ESR1—uterine fibroid	0.0001	0.000331	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP17A1—uterine fibroid	9.83e-05	0.000326	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MED12—uterine fibroid	9.65e-05	0.00032	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MED12—uterine fibroid	9.56e-05	0.000317	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—ESR1—uterine fibroid	9.01e-05	0.000298	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—ESR1—uterine fibroid	8.82e-05	0.000292	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP17A1—uterine fibroid	8.57e-05	0.000284	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—ESR1—uterine fibroid	8.36e-05	0.000277	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP17A1—uterine fibroid	8.07e-05	0.000267	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP17A1—uterine fibroid	8e-05	0.000265	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—ESR1—uterine fibroid	7.23e-05	0.000239	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MED12—uterine fibroid	6.31e-05	0.000209	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP17A1—uterine fibroid	5.28e-05	0.000175	CbGpPWpGaD
